IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival-Reference-Cited by-同舟云学术

IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival

Published:2017-06-14 Issue:6 Volume:12 Page:e0178939
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gungor Ozkan,Unal Hilmi Umut,Guclu Aydin,Gezer Mustafa,Eyileten Tayfun,Guzel Fatma Betül,Altunoren Orcun,Erken Ertugrul,Oguz Yusuf,Kocyigit Ismail,Yilmaz Mahmut Ilker

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. PLoS One;NR Hill;PLoS One,2016

2. Prediction, progression, and outcomes of chronic kidney disease in older adults;S Anderson;J Am Soc Nephrol.,2009

3. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal;JJ Carrero;Clin J Am Soc Nephrol,2009

4. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes;MI Yilmaz;Clin J Am Soc Nephrol,2011

5. The relationship between IL-10 levels and cardiovascular events in patients with CKD;MI Yilmaz;Clin J Am Soc Nephrol,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amniotic fluid proteomic analysis identifies IL1RL1, APOE, and NECTIN4 as new biomarkers for preterm birth;BMC Pregnancy and Childbirth;2024-08-12

2. Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease;Kidney International Reports;2024-06

3. Advancements in diabetic kidney disease management: integrating innovative therapies and targeted drug development;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01

4. Association of soluble suppression of tumorigenicity 2 with mortality and adverse outcomes in chronic kidney disease: a systematic review and meta-analysis;Clinical and Experimental Nephrology;2024-04-27

5. Osteoprotegerin and Inflammation in Incident Peritoneal Dialysis Patients;Journal of Clinical Medicine;2024-04-18